These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25855920)

  • 21. Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone.
    Liao L; Yang M; Qiu LL; Mou YR; Zhao JJ; Dong JJ
    Chin Med J (Engl); 2010 Dec; 123(24):3684-8. PubMed ID: 22166651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pioglitazone versus glipizide on body fat distribution, body water content, and hemodynamics in type 2 diabetes.
    Basu A; Jensen MD; McCann F; Mukhopadhyay D; Joyner MJ; Rizza RA
    Diabetes Care; 2006 Mar; 29(3):510-4. PubMed ID: 16505497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy and safety of pioglitazone hydrochloride in combination with sulphonylureas and metfomin in the treatment of type 2 diabetes mellitus a 12-week randomized multi-centres placebo-controlled parallel study].
    Pan C; Gao Y; Gao X; Li G; Luo B; Shi H; Tian H; Jia P; Lin H; Xing X; Zhao Y; Zhou L
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):388-92. PubMed ID: 12137601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effect of addition of beraprost sodium to pioglitazone treatment on the blood glucose levels in patients with type 2 diabetes mellitus.
    Chen T; Kusunoki M; Sato D; Tsutsui H; Nakamura T; Miyata T; Oshida Y
    Exp Clin Endocrinol Diabetes; 2013 Nov; 121(10):624-7. PubMed ID: 24002894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
    Saxena T; Maheshwari S; Goyal RK
    J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rosiglitazone produces a greater reduction in circulating platelet activity compared with gliclazide in patients with type 2 diabetes mellitus--an effect probably mediated by direct platelet PPARgamma activation.
    Khanolkar MP; Morris RH; Thomas AW; Bolusani H; Roberts AW; Geen J; Jackson SK; Evans LM
    Atherosclerosis; 2008 Apr; 197(2):718-24. PubMed ID: 17765245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.
    Esteghamati A; Afarideh M; Feyzi S; Noshad S; Nakhjavani M
    Diabetes Metab Syndr; 2015; 9(4):258-65. PubMed ID: 25450818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
    Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
    Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia.
    Pfützner A; Schöndorf T; Tschöpe D; Lobmann R; Merke J; Müller J; Lehmann U; Fuchs W; Forst T
    Diabetes Technol Ther; 2011 Jun; 13(6):637-43. PubMed ID: 21457065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy.
    Agarwal R; Saha C; Battiwala M; Vasavada N; Curley T; Chase SD; Sachs N; Semret MH
    Kidney Int; 2005 Jul; 68(1):285-92. PubMed ID: 15954919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meal fat storage in subcutaneous adipose tissue: comparison of pioglitazone and glipizide treatment of type 2 diabetes.
    Basu A; Basu R; Pattan V; Rizza RA; Jensen MD
    Obesity (Silver Spring); 2010 Oct; 18(10):2058-60. PubMed ID: 20539300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of mild agonist stimulation on the platelet reactivity in patients with type 2 diabetes mellitus.
    Mahmoodian R; Salimian M; Hamidpour M; Khadem-Maboudi AA; Gharehbaghian A
    BMC Endocr Disord; 2019 Jun; 19(1):62. PubMed ID: 31200678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Brain-Derived Neurotrophic Factor is Related to Platelet Reactivity and Metformin Treatment in Adult Patients With Type 2 Diabetes Mellitus.
    Eyileten C; Mirowska-Guzel D; Milanowski L; Zaremba M; Rosiak M; Cudna A; Kaplon-Cieslicka A; Opolski G; Filipiak KJ; Malek L; Postula M
    Can J Diabetes; 2019 Feb; 43(1):19-26. PubMed ID: 29891331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes.
    Randriamboavonjy V; Isaak J; Elgheznawy A; Pistrosch F; Frömel T; Yin X; Badenhoop K; Heide H; Mayr M; Fleming I
    Blood; 2012 Jul; 120(2):415-23. PubMed ID: 22665935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes.
    Zhang Y; Chen R; Jia Y; Chen M; Shuai Z
    Drug Des Devel Ther; 2021; 15():3027-3040. PubMed ID: 34285470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukopenia and thrombocytopenia caused by thiazolidinediones.
    Digman C; Klein AK; Pittas AG
    Ann Intern Med; 2005 Sep; 143(6):465-6. PubMed ID: 16172449
    [No Abstract]   [Full Text] [Related]  

  • 39. Pioglitazone protects against thrombosis in a mouse model of obesity and insulin resistance.
    Bodary PF; Vargas FB; King SA; Jongeward KL; Wickenheiser KJ; Eitzman DT
    J Thromb Haemost; 2005 Oct; 3(10):2149-53. PubMed ID: 16194192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of hydrochloride pioglitazone on urinary 8-hydroxy -deoxyguanosine excretion in type 2 diabetics.
    Wang Y; Ye S; Hu Y; Zhao L; Zheng M
    J Diabetes Complications; 2013; 27(1):75-7. PubMed ID: 23021797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.